SHALLCROSS STEVEN A
SEC CIK 1263501 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TOVX | Theriva Biologics, Inc. | CEO, CFO, Dir | 250.0K | $160.0K | — | 7 | 2022-12-29 | 2023-06-07 |
Most active insiders at TOVX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
SHALLCROSS STEVEN A made no open-market trades at TOVX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-08 | 2023-06-07 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $0.69 | +14.0K | 250.0K | +6% | +$9,660 | |
| 2023-06-07 | 2023-06-06 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $0.63 | +26.0K | 236.0K | +12% | +$16.4K | |
| 2023-02-13 | 2023-02-10 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $1.04 | +25.0K | 210.0K | +14% | +$26.0K | |
| 2023-02-03 | 2023-02-02 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $0.94 | +25.0K | 185.0K | +16% | +$23.5K | |
| 2023-01-26 | 2023-01-25 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $0.87 | +25.0K | 160.0K | +19% | +$21.8K | |
| 2023-01-23 | 2023-01-20 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $0.75 | +25.0K | 135.0K | +23% | +$18.8K | |
| 2023-01-03 | 2022-12-29 | TOVX | Theriva Biologics, Inc. | SHALLCROSS STEVEN A | CEO, CFO, Dir | P - Purchase | $0.44 | +100.0K | 110.0K | +1,000% | +$44.0K |
Purchase Sale Sale after option exercise All abbreviations